Giulia Romano
Giulia Romano
Virginia Commonwealth University
Verified email at
Cited by
Cited by
miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation
M Garofalo, G Di Leva, G Romano, G Nuovo, SS Suh, A Ngankeu, ...
Cancer cell 16 (6), 498-509, 2009
EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
M Garofalo, G Romano, G Di Leva, G Nuovo, YJ Jeon, A Ngankeu, J Sun, ...
Nature medicine 18 (1), 74-82, 2012
MicroRNA and cancer–a brief overview
M Acunzo, G Romano, D Wernicke, CM Croce
Advances in biological regulation 57, 1-9, 2015
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer
M Garofalo, C Quintavalle, G Di Leva, C Zanca, G Romano, C Taccioli, ...
Oncogene 27 (27), 3845-3855, 2008
miR221/222 in cancer: their role in tumor progression and response to therapy
M Garofalo, C Quintavalle, G Romano, C M croce, G Condorelli
Current molecular medicine 12 (1), 27-33, 2012
Contrast agents and renal cell apoptosis
G Romano, C Briguori, C Quintavalle, C Zanca, NV Rivera, A Colombo, ...
European heart journal 29 (20), 2569-2576, 2008
miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222
M Acunzo, R Visone, G Romano, A Veronese, F Lovat, D Palmieri, ...
Oncogene 31 (5), 634-642, 2012
miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ
C Quintavalle, M Garofalo, C Zanca, G Romano, M Iaboni, MB De Caro, ...
Oncogene 31 (7), 858-868, 2012
MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation
G Romano, M Acunzo, M Garofalo, G Di Leva, L Cascione, C Zanca, ...
Proceedings of the National Academy of Sciences 109 (41), 16570-16575, 2012
MiR-212 increases tumor necrosis factor–related apoptosis-inducing ligand sensitivity in non–small cell lung cancer by targeting the antiapoptotic protein PED
M Incoronato, M Garofalo, L Urso, G Romano, C Quintavalle, C Zanca, ...
Cancer research 70 (9), 3638-3646, 2010
Small non-coding RNA and cancer
G Romano, D Veneziano, M Acunzo, CM Croce
Carcinogenesis 38 (5), 485-491, 2017
Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells
C Quintavalle, E Donnarumma, M Iaboni, G Roscigno, M Garofalo, ...
Oncogene 32 (34), 4001-4008, 2013
Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2
M Acunzo, G Romano, D Palmieri, A Laganį, M Garofalo, V Balatti, ...
Proceedings of the National Academy of Sciences 110 (21), 8573-8578, 2013
MiR-34a/c-dependent PDGFR-α/β downregulation inhibits tumorigenesis and enhances TRAIL-induced apoptosis in lung cancer
M Garofalo, YJ Jeon, GJ Nuovo, J Middleton, P Secchiero, P Joshi, ...
PloS one 8 (6), e67581, 2013
MiR-221/222 target the DNA methyltransferase MGMT in glioma cells
C Quintavalle, D Mangani, G Roscigno, G Romano, A Diaz-Lagares, ...
PloS one 8 (9), e74466, 2013
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis
S Catuogno, L Cerchia, G Romano, P Pognonec, G Condorelli, ...
Oncogene, 2012
UCbase & miRfunc: a database of ultraconserved sequences and microRNA function
C Taccioli, E Fabbri, R Visone, S Volinia, GA Calin, LY Fong, R Gambari, ...
Nucleic Acids Research 37 (suppl_1), D41-D48, 2009
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b
G Roscigno, C Quintavalle, E Donnarumma, I Puoti, A Diaz-Lagares, ...
Oncotarget 7 (1), 580, 2016
RNA nanoparticle-based targeted therapy for glioblastoma through inhibition of oncogenic miR-21
TJ Lee, JY Yoo, D Shu, H Li, J Zhang, JG Yu, AC Jaime-Ramirez, ...
Molecular Therapy 25 (7), 1544-1555, 2017
miR-579-3p controls melanoma progression and resistance to target therapy
L Fattore, R Mancini, M Acunzo, G Romano, A Laganą, ME Pisanu, ...
Proceedings of the National Academy of Sciences 113 (34), E5005-E5013, 2016
The system can't perform the operation now. Try again later.
Articles 1–20